Published in Brain Res on October 29, 1993
Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Mol Ther (2005) 2.02
A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc Natl Acad Sci U S A (1997) 1.83
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease. Br J Pharmacol (2011) 1.39
Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats. Cell Stem Cell (2010) 1.35
GDNF is not required for catecholaminergic neuron survival in vivo. Nat Neurosci (2015) 1.25
Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc Natl Acad Sci U S A (1997) 1.14
Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states. Eur J Neurosci (2008) 1.07
Pronounced microgliosis and neurodegeneration in aged rats after tau gene transfer. Neurobiol Aging (2009) 1.03
Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation. PLoS One (2009) 1.00
Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease. Proc Natl Acad Sci U S A (1999) 0.98
Cell-based therapies for Parkinson disease—past insights and future potential. Nat Rev Neurol (2015) 0.97
Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease. Brain Res (2008) 0.90
Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease. Psychopharmacology (Berl) (2007) 0.88
Within-session analysis of amphetamine-elicited rotation behavior reveals differences between young adult and middle-aged F344/BN rats with partial unilateral striatal dopamine depletion. Pharmacol Biochem Behav (2010) 0.86
Use of [18F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats. EJNMMI Res (2011) 0.86
Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia. J Neurochem (2011) 0.86
The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. J Physiol (2009) 0.85
Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease. BMC Neurosci (2012) 0.85
The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson's disease rat model. Neurol Sci (2010) 0.85
Dopamine neuron stimulating actions of a GDNF propeptide. PLoS One (2010) 0.83
Murine model for Parkinson's disease: from 6-OH dopamine lesion to behavioral test. J Vis Exp (2010) 0.83
Antioxidant effect of Spirulina (Arthrospira) maxima in a neurotoxic model caused by 6-OHDA in the rat striatum. J Neural Transm (Vienna) (2013) 0.81
ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion. J Neurochem (2014) 0.81
Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake. PLoS One (2012) 0.80
Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model. Mol Neurobiol (2013) 0.80
Young and middle-aged rats exhibit isometric forelimb force control deficits in a model of early-stage Parkinson's disease. Behav Brain Res (2011) 0.80
Differential effects of dopamine D1 and D 2/3 receptor antagonism on motor responses. Psychopharmacology (Berl) (2014) 0.79
Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway. Psychopharmacology (Berl) (2011) 0.79
Monoamine reuptake inhibitors in Parkinson's disease. Parkinsons Dis (2015) 0.78
Striatal glutamate release in L-DOPA-induced dyskinetic animals. PLoS One (2013) 0.78
Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats. Exp Brain Res (2003) 0.78
L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors. J Neural Transm (Vienna) (2006) 0.77
Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease. Stem Cells Transl Med (2016) 0.75
Longitudinal imaging of the availability of dopamine transporter and D2 receptor in rat striatum following mild ischemia. J Cereb Blood Flow Metab (2016) 0.75
Evidence of D-phenylglycine as delivering tool for improving L-dopa absorption. J Biomed Sci (2010) 0.75
Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease. J Neurosci Methods (2015) 0.75
Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson's Disease Are Related to Its Anti-Inflammatory Effects. Neurochem Res (2017) 0.75
Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats. J Neural Transm (Vienna) (2004) 0.75
GEL, a DNA sequencing project management system. Nucleic Acids Res (1982) 18.85
SEQ: a nucleotide sequence analysis and recombination system. Nucleic Acids Res (1982) 8.73
Patients' action during their cardiac event: qualitative study exploring differences and modifiable factors. BMJ (1998) 7.00
Dopamine neuron agenesis in Nurr1-deficient mice. Science (1997) 5.40
Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell (1988) 4.47
Defects in enteric innervation and kidney development in mice lacking GDNF. Nature (1996) 3.82
A multifactor complex of eukaryotic initiation factors, eIF1, eIF2, eIF3, eIF5, and initiator tRNA(Met) is an important translation initiation intermediate in vivo. Genes Dev (2000) 3.39
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature (1995) 2.69
Functional recovery in parkinsonian monkeys treated with GDNF. Nature (1996) 2.35
Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol (1989) 2.22
Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci U S A (1992) 2.16
Multiple roles for the C-terminal domain of eIF5 in translation initiation complex assembly and GTPase activation. EMBO J (2001) 2.06
Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci (1998) 1.91
Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother (1998) 1.89
Adenine nucleotides and synaptic transmission in the in vitro rat hippocampus. Br J Pharmacol (1980) 1.78
Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science (1979) 1.74
Combined serotyping and biotyping of Serratia marcescens. J Clin Microbiol (1976) 1.64
Self-referencing ceramic-based multisite microelectrodes for the detection and elimination of interferences from the measurement of L-glutamate and other analytes. Anal Chem (2001) 1.63
Removal of constricting bands using the Dremel drill. Acad Emerg Med (1999) 1.57
Microelectrode array studies of basal and potassium-evoked release of L-glutamate in the anesthetized rat brain. J Neurochem (2006) 1.56
Development and regional expression of beta nerve growth factor messenger RNA and protein in the rat central nervous system. Proc Natl Acad Sci U S A (1986) 1.56
Activation of the pathway from locus coeruleus to rat cerebellar Purkinje neurons: pharmacological evidence of noradrenergic central inhibition. J Pharmacol Exp Ther (1973) 1.55
Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis. Brain Res (1971) 1.55
Actin. Protein Profile (1995) 1.55
Intercellular communication in the brain: wiring versus volume transmission. Neuroscience (1995) 1.50
Activation of a central noradrenergic projection to cerebellum. Nature (1971) 1.48
Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J Neurosci (1997) 1.48
Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res (2001) 1.46
Ceramic-based multisite microelectrodes for electrochemical recordings. Anal Chem (2000) 1.45
Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull (1987) 1.44
Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem (1999) 1.43
Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci (1999) 1.42
Alpha-bungarotoxin binding to hippocampal interneurons: immunocytochemical characterization and effects on growth factor expression. J Neurosci (1993) 1.42
Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett (1994) 1.40
Levobupivacaine for low-dose spinal anaesthesia. Br J Anaesth (2014) 1.39
Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. 3. Evidence for mediation of norepinephrine effects by cyclic 3',5'-adenosine monophosphate. Brain Res (1971) 1.36
A special feeding technique for chronic regurgitation. Am J Ment Defic (1974) 1.35
Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res (1984) 1.34
The dextro and levorotatory isomers of N-phenylisopropyladenosine: stereospecific effects on cyclic AMP-formation and evoked synaptic responses in brain slices. Life Sci (1979) 1.32
Critical decline in fine motor hand movements in human aging. Neurology (1999) 1.32
Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res Bull (1995) 1.29
Cyclic adenosine monophosphate: possible mediator for norepinephrine effects on cerebellar Purkinje cells. Science (1969) 1.26
Second-by-second measures of L-glutamate in the prefrontal cortex and striatum of freely moving mice. J Pharmacol Exp Ther (2007) 1.26
In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J Pharmacol Exp Ther (1999) 1.26
Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys. Brain Res (2000) 1.25
Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci U S A (1995) 1.24
o-Phenylenediamine-modified carbon fiber electrodes for the detection of nitric oxide. Anal Chem (1996) 1.24
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp Neurol (2006) 1.23
Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents. Neuroscience (2007) 1.22
An analysis of the prevalence and incidence of gynecologic cancer cytologically detected in a population of 175,767 women. Acta Cytol (1970) 1.21
Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology (2000) 1.20
Regional effects of aging on dopaminergic function in the Fischer-344 rat. Neurobiol Aging (1992) 1.19
Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett (1994) 1.19
Postnatal development of electrical and enzyme histochemical activity in Purkinje cells. Exp Neurol (1969) 1.19
Microiontophoretic release of norepinephrine from micropipettes. Neuropharmacology (1971) 1.19
Studies on norepinephrine-containing afferents to Purkinje cells of art cerebellum. I. Localization of the fibers and their synapses. Brain Res (1971) 1.18
Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J Neurochem (1992) 1.18
Theoretical variance analysis of single- and dual-energy computed tomography methods for calculating proton stopping power ratios of biological tissues. Phys Med Biol (2010) 1.16
A method for detecting intracellular cyclic adenosine monophosphate by immunofluorescence. J Histochem Cytochem (1972) 1.12
The ontogenetic development of synaptic junctions, synaptic activation and responsiveness to neurotransmitter substances in rat cerebellar purkinje cells. Brain Res (1971) 1.11
In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions. Exp Neurol (2001) 1.10
Real time in vivo measures of L-glutamate in the rat central nervous system using ceramic-based multisite microelectrode arrays. Ann N Y Acad Sci (2003) 1.09
Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke (2001) 1.08
Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Res (1996) 1.08
Fission yeast homolog of murine Int-6 protein, encoded by mouse mammary tumor virus integration site, is associated with the conserved core subunits of eukaryotic translation initiation factor 3. J Biol Chem (2000) 1.08
Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J Neurochem (1993) 1.08
Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J Pharmacol Exp Ther (1996) 1.07
Age-related changes in the dynamics of potassium-evoked L-glutamate release in the striatum of Fischer 344 rats. J Neural Transm (Vienna) (2004) 1.06
Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease. Brain Res (2004) 1.06
Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats. Brain Res (1998) 1.06
c-fos reduces corticosterone-mediated effects on neurotrophic factor expression in the rat hippocampal CA1 region. J Neurosci (2003) 1.05
The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study. Brain Res (1988) 1.03
Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy. J Neurosci (1996) 1.03
Modulatory actions of norepinephrine in the central nervous system. Fed Proc (1979) 1.03
Bilateral 6-OHDA lesions of the locus coeruleus impair associative olfactory learning in newborn rats. Brain Res (1994) 1.03
Benzodiazepines and central inhibitory mechanisms. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.03
Multiple single-unit recordings in the striatum of freely moving animals: effects of apomorphine and D-amphetamine in normal and unilateral 6-hydroxydopamine-lesioned rats. Brain Res (1999) 1.02
Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J Pharmacol Exp Ther (1997) 1.02
Corticosterone actions on the hippocampal brain-derived neurotrophic factor expression are mediated by exon IV promoter. J Neuroendocrinol (2006) 1.02
Fuzzy logic in computer-aided breast cancer diagnosis: analysis of lobulation. Artif Intell Med (1997) 1.02
Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.02
Effects of serotonin on central neurons: microiontophoretic administration. Fed Proc (1972) 1.01
A multifactor complex of eIF1, eIF2, eIF3, eIF5, and tRNA(i)Met promotes initiation complex assembly and couples GTP hydrolysis to AUG recognition. Cold Spring Harb Symp Quant Biol (2001) 1.01
GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area. J Comp Neurol (2001) 1.01
Cyclic adenosine monophosphate and norepinephrine: effects on transmembrane properties of cerebellar Purkinje cells. Science (1971) 1.01
Tositumomab and iodine I 131 tositumomab for recurrent indolent and transformed B-cell non-Hodgkin's lymphoma. J Clin Oncol (2004) 1.00
A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain. Brain Res (1999) 1.00
Cyclic AMP-mediated adrenergic synapses to cerebellar Purkinje cells. Adv Cyclic Nucleotide Res (1972) 1.00
5-HT(1B) receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. J Neurochem (2000) 1.00
Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice. Brain Res (1987) 1.00
Fabrication and characterization of sputtered-carbon microelectrode arrays. Anal Chem (1996) 1.00
Glial cell line-derived neurotrophic factor receptor alpha1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles. Neuroscience (2000) 1.00
Identification of Mycobacterium DNA in an Egyptian Pott's disease of 5,400 years old. C R Acad Sci III (1998) 1.00
Interaction of norepinephrine with cerebellar activity evoked by mossy and climbing fibers. Exp Neurol (1977) 0.99
In vivo assessment of dopamine uptake in rat medial prefrontal cortex: comparison with dorsal striatum and nucleus accumbens. J Neurochem (1995) 0.99